Spago Nanomedical
0.198
SEK
-0.5 %
Less than 1K followers
SPAGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
-0.5%
-5.71%
+1.02%
+10.61%
-12.39%
-33.11%
-94.45%
-97.39%
-98.26%
Spago Nanomedical conducts research and development in cancer diagnostics. The company conducts various development projects based on its proprietary nanomaterials whose potential is found in making tumours visible, and enabling internal radiation therapy of cancer. The company was founded in 2007 and is based in Lund.
Read moreMarket cap
68.94M SEK
Turnover
2.97K SEK
Revenue
1.91M
EBIT %
-1,764.92 %
P/E
-
Dividend yield-%
-
Financial calendar
7.5
2025
Interim report Q1'25
14.5
2025
General meeting '25
20.8
2025
Interim report Q2'25
All
Press releases
ShowingAll content types
BioStock: Spago takes Tumorad-01 study to the next level
Carnegie Access: Spago Nanomedical: Clears the next hurdle
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools